Japan Tobacco International announced a €300 million investment to build a new, state-of-the-art factory in Ștefăneștii de Jos, marking its next step after more than 30 years of operations in Romania. In a LinkedIn post, JTI said the facility will add nearly 70,000 square meters of production space and feature advanced equipment, 100% renewable energy operations, expanded waste management, and a dedicated water treatment system, underscoring the company’s long-term commitment to sustainable manufacturing in the country.
Blog
-
Al Fakher to Debut Nicotine Pouches
Al Fakher, best known for its hookah products, announced the launch of Al Fakher Nicotine Pouches today (March 31) at the Total Products Expo in Las Vegas, marking the brand’s entry into the tobacco-free oral nicotine category. The product line debuts with four flavors—Frosty Apple, Spearmint, Mango, and Wintergreen—each offered in 4 mg and 8 mg strengths, and will roll out broadly in April 2026 following the show.
-
BAT Malaysia to Trim Workforce
British American Tobacco Malaysia Bhd said it may reduce its workforce as part of an operational “optimization” linked to the rollout of a new route-to-market distribution model from July 1. In a filing today (March 31), the company said affected employees would receive statutory and contractual entitlements, including retrenchment benefits where applicable. BAT Malaysia reported 283 employees in its 2024 annual report, but the filing did not specify how many roles could be impacted. The company said the move is intended to align staffing with future operating requirements and follows a shift begun in 2022 toward allowing retailers to place orders through online channels, sales representatives, or call centers, a model it previously said could reduce costs by 20% to 25%.
The announcement comes amid tighter regulation of tobacco products in Malaysia, including a reported plan for a nationwide vape ban starting with disposable products, a 42.8% excise duty increase on tobacco and heated tobacco products under Budget 2026, new pictorial health warnings, and a ban on retail cigarette displays. The Control of Smoking Products for Public Health Act, which took effect in 2024, prohibits the sale of tobacco and vape products to individuals under 18. Shares of BAT Malaysia last traded at RM5.65 ($1.41) at today’s noon break, valuing the company at RM1.61 billion ($403 million).
-
Charlotte’s Web Announces Financials, Deal with BAT
Charlotte’s Web Holdings, Inc. announced a transaction with BT DE Investments yesterday (March 30), a subsidiary of British American Tobacco, to convert a $54.2 million convertible debenture plus accrued interest into equity at $0.68 per share and complete a concurrent $10 million private placement, resulting in the issuance of about 110 million shares and a total equity commitment of roughly $75 million. The deal would eliminate about $65 million in debt, stop future interest accrual, and leave the company with no long-term debt, subject to shareholder and TSX approval at a meeting planned for May 28, 2026.
Today (March 31), the company released its 2025 financials and said it advanced product innovation, in-house manufacturing, and healthcare channel development while holding annual revenue broadly steady at $49.9 million. Fourth-quarter revenue rose 4.7% year over year to $13.3 million, supported by new Brightside low-dose hemp THC gummies, sleep products, functional mushrooms, and minor cannabinoids, though gross margin was affected by a one-time inventory charge tied to legacy gummies. Full-year gross margin improved to 43.5% and SG&A fell 21% to $42 million following cost reductions, narrowing the operating loss to $20.3 million from $32 million in 2024. The company ended the year with $8 million in cash and reported progress toward internalizing gummy production, achieving a clean NSF 455-2 cGMP audit, and establishing a Scientific Advisory Board to support its expanding medical practitioner channel.
Charlotte’s Web said the strengthened balance sheet will support its planned participation in a Centers for Medicare & Medicaid Innovation pilot enabling access to hemp-derived CBD products for Medicare beneficiaries and ongoing clinical development by DeFloria, its joint venture with BAT and Ajna BioSciences, which is preparing to begin Phase 2 trials of a botanical CBD-based treatment candidate in mid-2026.
-
Nicokick Urges Clarity on Smoke-Free Information
Nicokick.com, owned by Haypp Group, called on policymakers and health professionals to provide clearer, evidence-based information distinguishing the risks of combustible cigarettes from non-combusted nicotine products. The appeal follows a report by the Foundation for American Innovation highlighting high tobacco and nicotine use among U.S. servicemembers and recommending that institutions recognize differences between product types when addressing health and readiness. Nicokick cited the U.S. Food and Drug Administration’s recognition of a “continuum of risk” across tobacco products and said improved adult-focused communication could help consumers and healthcare professionals better understand these distinctions while reinforcing that smoke-free products are intended only for existing adult users.
-
PM Offers IQOS Specials to Promote Korean Expansion
Korea Philip Morris said it will expand retail availability of its new “Electric Purple” color for the IQOS Iluma i One to major convenience stores nationwide from May 2. The color, first introduced on April 10 through the official IQOS online store and nine branded outlets, features a deep purple tone with a bluish tint. To mark the wider rollout, the company will run a promotion through May 20 a discounted price in the 30,000-won ($19.80) range for its devices in all colors.
-
PMI Releases Value Report 2025, Sets Value Plan 2030+
Philip Morris International released its Value Report 2025, marking the completion of its 2025 Roadmap and introducing a new Value Plan 2030+ to guide future growth. The report outlines progress in PMI’s shift toward smoke-free products and details performance across business transformation, environmental, and social metrics. In 2025, PMI reported around 43.5 million adult users of its smoke-free products across 106 markets, with smoke-free net revenues reaching $16.9 billion, representing 41.5% of total annual net revenues.
The company also reported 98% coverage of shipment volumes with youth access prevention programs in indirect retail channels, 91% coverage with anti-littering programs for cigarette butts, and 76% of employees having access to structured lifelong learning opportunities. Among agricultural metrics, PMI said 99.6% of contracted farmers supplying tobacco achieved a living income, while 99.3% of tobacco purchased was at no risk of net deforestation. PMI reported a 46% reduction in absolute Scope 1 and 2 greenhouse gas emissions compared with 2019 and a 31% reduction in Scope 3 Forest, Land, and Agriculture emissions compared with 2010.
PMI said its Value Plan 2030+ will focus on six priorities: consumers and product health impact, circularity, climate change, nature and biodiversity, its workforce, and workers across its value chain. The company stated the report was prepared with reference to Global Reporting Initiative standards and guidance from the International Sustainability Standards Board.
-
Bangladesh Reversing Vape Ban
Bangladesh is preparing amendments to its anti-tobacco ordinance that would withdraw the ban on the production, import, sale, and use of e-cigarettes and other electronic nicotine delivery systems, and remove restrictions on displaying tobacco products at points of sale. The ordinance, approved in December 2025 by the interim government, expanded the definition of tobacco products and introduced penalties for activities involving e-cigarettes, vapes, heated tobacco products, and similar devices. These included jail terms, fines, seizure of goods, and possible license revocation for companies.
The proposed changes follow recommendations from a parliamentary special committee reviewing 133 ordinances, with the health ministry drafting amendments to omit the relevant provisions for submission to the Legislative and Parliamentary Affairs Division. Health Secretary Md Quamruzzaman Chowdhury said the ministry would act in accordance with the committee’s recommendations regarding the ordinances under its jurisdiction.
-
Geekvape Introduces New Products in Paris
Geekvape introduced several new products at Vapexpo Paris, including the Force device and the Aegis Mini 5, expanding its performance-focused and durability-oriented portfolio. The company also highlighted the Legend 5 10th Anniversary Edition within its Aegis series, alongside Neutra, a refillable system designed with environmental considerations. The launches were presented within a “Future Store Experience” concept booth that reflected Geekvape’s updated retail visual identity and integrated product display with sustainability themes.
-
Organigram Shares Results of AGM, Gains Approval for Sanity Acquisition
Shareholders of Organigram Global Inc. overwhelmingly approved the company’s proposed acquisition of Germany-based Sanity Group GmbH and a related private placement with British American Tobacco subsidiary BT DE Investments at a meeting held on March 30. The transaction resolution passed with 93% of votes cast, excluding shares associated with BAT, and authorizes Organigram to issue up to 96.3 million common shares to Sanity Group shareholders and BAT in connection with the deal.
The acquisition, expected to close in April subject to customary conditions, is positioned to expand Organigram’s presence from its leading position in Canada’s adult-use market into the German medical cannabis sector and establish a broader European operational footprint. Shareholders also approved the election of 10 directors, the reappointment of PricewaterhouseCoopers LLP as auditor, and the approval of unallocated awards under the company’s long-term equity incentive plan.